+441764910199 
Editorial
Supplementation of Vitamin D in Patients with Sickle Cell Bone Disease: A Dbate or a Combate?
| Farid Menaa* | ||
| Executive Director and Professor, Fluorotronics, Inc. CA, USA | ||
| Corresponding Author : | Farid Menaa Executive Director and Professor Fluorotronics, Inc. CA, USA Tel: (760) 599-9496 E-mail: [email protected] |
|
| Received July 29, 2014; Accepted July 29, 2014; Published July 31, 2014 | ||
| Citation: Menaa F (2014) Supplementation of Vitamin D in Patients with Sickle Cell Bone Disease: A D-bate or a Combate?. J Hematol Thrombo Dis 2:e115 doi:10.4172/2329-8790.1000e115 | ||
| Copyright: © 2014 Menaa F. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. | ||
Related article at Pubmed Scholar Google |
||
Abstract
After its discovery as a genetically inherited hemoglobinopathy one hundred years ago, finding a widely available cure for sickle cell anemia (SCA, HbSS) still remains a challenge and the disease requires multi-disciplinary theranostic approaches (Menaa et al., 2013; Menaa, 2014). Indeed, more effort and resources to promptly find alternative therapeutics and/or adjuvants (e.g. nutraceutics) to HU
